IMUGENE LIMITED (IMU)
An Australian pharmaceutical company with a platform drug delivery platform technology at the centre of its assets. The platform allows drugs in tablet form to be delivered straight into the blood stream via the mouth accelerating onset of action and reducing side effects of absorption in the stomach.On this page you will find:
|
Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options |
|
Company details Closing prices Dividends Warrants & Structured Products ASX CFDs |
Delayed share price
Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.
| Code | Last | % Chg | Bid | Offer | Open | High | Low | Vol |
|---|---|---|---|---|---|---|---|---|
| IMU | 0.008 | -11.11% | 0.007 | 0.008 | 0.008 | 0.008 | 0.008 | 250,000 |
ASX Find a broker tool
Helps you find an ASX broker based on your needs and where you live.
IMUGENE LIMITED details
Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.
| Issuer Code | IMU |
|---|---|
| Securities | |
| Official Listing Date | 24 November, 1993 |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences |
| Exempt Foreign? | No |
| Internet Address | http://www.imugene.com |
| Registered Office Address | Suite 1, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3142 |
| Head Office Telephone | 03 9824 5254 |
| Head Office Fax | 03 9822 7735 |
| Share Registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000 |
| Share Registry Telephone | 1300 787 272 |
| Directors / Senior Management |
|---|
|
Mr Steve Harris (Non Exec. Chairman) Dr Nicholas Ede (Executive Director) Mr Paul Hopper (Non Exec. Director) Mr Phillip Hains (CFO) |
| Company Secretary |
Mr Justyn Stedwell Mr Phillip Hains (Joint Co. Secretary) |
|---|---|
| Principal Activities | An Australian pharmaceutical company with a platform drug delivery platform technology at the centre of its assets. The platform allows drugs in tablet form to be delivered straight into the blood stream via the mouth accelerating onset of action and reducing side effects of absorption in the stomach. |
IMUGENE LIMITED announcements
How are company announcements published on www.asx.com.au?
| Date | Price sens. |
Headline | Pages | |
|---|---|---|---|---|
| 08/05/2013 | Research Report on Imugene Drug Delivery Technology | 1 | ||
| 02/05/2013 | Shareholder Newsletter | 4 | ||
| 01/05/2013 | Investor Presentation | 15 | ||
| 30/04/2013 |
|
Share Purchase Plan - Offer Document | 21 | |
| 30/04/2013 |
|
Share Purchase Plan | 2 | |
| 30/04/2013 | Share Purchase Plan - Cleansing Notice | 1 | ||
| 30/04/2013 |
|
Imugene granted Chinese patent | 2 | |
| 29/04/2013 |
|
Appendix 4C - quarterly | 5 | |
| 05/03/2013 |
|
Imugene to be awarded Japanese patent | 2 | |
| 28/02/2013 |
|
Half Year Financial Results | 2 |
> search for past company announcements
Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.
Closing prices
Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.
| Date | Last | % Change | High | Low | Vol * |
|---|---|---|---|---|---|
| 17 May 2013 | 0.008 | -11.11% | 0.008 | 0.008 | 250,000 |
| 13 May 2013 | 0.009 | 0% | 0.009 | 0.009 | 20,000 |
| 10 May 2013 | 0.009 | 12.5% | 0.009 | 0.008 | 453,092 |
| 03 May 2013 | 0.008 | -20% | 0.008 | 0.008 | 66,908 |
| 01 May 2013 | 0.010 | 0% | 0.010 | 0.010 | 50,000 |
* Volume of shares shown represents only those shares traded on ASX.
IMUGENE LIMITED price history chart

Dividends
How are dividends released on www.asx.com.au?
No dividends have been found for the security IMU. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.
Exchange Traded Options
No Exchange Traded Options are available over the security IMU
Warrants & Structured Products
No warrants & Structured Products are available over the security IMU
ASX CFDs
No Contracts For Differences are available over the security IMU

